Results for “ ”

Entry Author Date Location
Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug 12/28/16 Boston
Ionis, Biogen Make History With FDA Nod for Spine Disease Drug 12/23/16 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Akebia Gets $265M From Otsuka to Bankroll Anemia Drug Push 12/20/16 Boston
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run 12/19/16 Boston
As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old Friends 12/19/16 Boston
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
Creating Bio “Gestalt” And Photos From New York Life Sciences 2021 12/19/16 New York
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another 12/15/16 Boston
Flagship Pioneers New Name, $285M ‘Special Opportunities’ Fund 12/15/16 Boston
Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease 12/14/16 Boston
Proteon’s Blood Vessel Drug Flunks Main Phase 3 Test, Shares Plummet 12/13/16 Boston
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
New York State Hatches Sprawling $650M Plan to Foster Biotech 12/12/16 New York
BlueRock Raises $225M To Repair Heart Damage With Stem Cells 12/12/16 Boston
San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis 12/12/16 San Diego
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song” 12/09/16 Indiana
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
Senate Approves 21st Century Cures Act, Sending Bill to Obama 12/07/16 National
Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study 12/07/16 Boston
First Clinical Trial Done, Elysium Lands $20M for Health Supplements 12/06/16 New York
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial 12/06/16 Seattle
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill 12/05/16 National
Fresh Off ASH Data, Spark Teams With Selecta to Boost Gene Therapies 12/05/16 Boston
Page 2 of 118 « previous page · next page »